Bill Gates acquired 105 Thousand Biomarin Pharmaceutical - Registered Shares shares worth $6.27 Million. That's 0.01% of their equity portfolio (22nd largest holding). Bill Gates acquired their 105 Thousand shares in Q1 2009. So far they never sold any shares in the company. The stake costed the investor $1.65 Million, netting the investor a gain of 280% so far.